The changes of macular blood flow density in patients of macular telangiectasis type 1 with macular edema before and after the treatment of anti-vascular endothelial growth factor
10.3760/cma.j.issn.1005-1015.2020.01.003
- VernacularTitle:动脉瘤型毛细血管扩张症伴黄斑水肿患眼抗血管内皮生长因子药物治疗前后黄斑区血流密度观察
- Author:
Yue ZHAO
1
;
Yan QI
;
Mudi YAO
;
Jin YAO
Author Information
1. 南京医科大学附属眼科医院 210029
- Keywords:
Regional blood flow;
Telangiectasis;
Macular edema;
Angiogenesis inhibitors/therapeutic use;
Tomography,optical coherence
- From:
Chinese Journal of Ocular Fundus Diseases
2020;36(1):10-14
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the changes ofmacular blood flow density in patients ofmacular telangiectasis type 1 (Mac-Tel type 1) with macular edema before and after the treatment of anti-VEGF.Methods A retrospective clinical study.From January 2016 to December 2017,14 Mac-Tel type 1 patients (14 eyes) diagnosed in Nanjing Medical University Eye Hospital were included in the study.There were 6 males (6eyes) and 8 females (8 eyes),with the mean age of 35.3± 9.3 years.All patients underwent BCVA and OCT angiography examinations.The BCVA examination was performed using the Snellen visual acuity chart,which was converted into logMAR visual acuity.All the patients were received anti-VEGF injection treatment once a month for 3 consecutive months.The OCTA scanning region in the macular area was 3 mm × 3 mm.Macular blood flow density in the superficial capillary plexus (SCP) and deep capillary plexus (DCP),the vessel density within a 300 μm width ring surrounding the foveal avascular area (FD-300) and central macular thickness (CMT)were measured in all eyes.Paired samples t-test and Pearson correlation analysis were used in this study.Results At the baseline,logMAR BCVA was 0.69 ± 0.07,CMT was 468.43 ± 26.59 μm,SCP blood flow density was (50.99± 1.19)％,DCP blood flow density was (43.79± 1.44)％,FD-300 was (50.73 ± 1.16)％.Compared with the baseline,there were significant differences between logMAR BCVA,CMT,DCP blood flow density and FD-300 in 1 week,1 month,3 months after treatment and 2 months after cessation of treatment (logMAR BCVA:t=6.77,13.30,16.99,9.51;P=0.00,0.01,0.00,0.01.CMT:t=6.99,15.88,26.10,6.50;P=0.00,0.01,0.01,0.00.DCP:t=6.75,8.61,15.12,7.63;P=0.00,0.01,0.01,0.00.FD-300:t=11.86,13.08,14.36,4.41;P=0.00,0.01,0.01,0.03).There was no significant difference in blood flow density of SCP between baseline and 2 months after cessation of treatment (t=1.36,P=0.19),but there was significant difference at the other time points after treatment (t=5.50,6.84,6.27;P=0.00,0.01,0.01).The Pearson's correlation analysis showed that there was a significant positive correlation between FD-300 and CMT (r2=0.54,P=0.04).Conclusions There is no significant change in the SCP blood flow density in the patients of Mac-Tel type 1 with macular edema,while the DCP blood flow density decreased and FD-300 increased.After anti-VEGF treatment,DCP blood flow density increased and FD-300 decreased.FD-300 is positively correlated with CMT.
